Artificial intelligence is entering a new phase in 2026: one where it evolves from a tool we use to a true partner in how we work, innovate, and solve complex problems. According to Microsoft’s AI outlook, this shift will redefine technology adoption across industries, transforming AI into a force that amplifies human potential and accelerates real-world impact.

In the life sciences sector, regulation has often been perceived as a constraint: a complex web of compliance requirements slowing innovation. We believe that technology, data, and a mindset shift toward collaboration are paving the way for a regulatory ecosystem that is not only adaptive, but also enabling and transforming compliance from a back-office process into a driver of strategic value. Read to find out why Vffice turns compliance into competitive advantage.

The pharmaceutical industry is undergoing one of the most significant shifts through digital transformation. This article delves into how digitalization is revolutionizing Life Sciences, highlighting the role of AI, ERP and CRM systems that drive efficiency, innovation, and compliance.